Innoviva
INVA
#5595
Rank
NZ$2.54 B
Marketcap
NZ$35.17
Share price
-0.19%
Change (1 day)
4.10%
Change (1 year)

Earnings for Innoviva (INVA)

Earnings in 2026 (TTM): NZ$1.03 Billion

According to Innoviva's latest financial reports the company's current earnings are NZ$0.42 Billion. In 2025 the company made an earning of NZ$0.54 Billion, an increase over its 2024 earnings that were of NZ$62.63 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innoviva from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$1.03 B88.49%
2025 NZ$0.54 B774.24%
2024 NZ$62.63 M-80.74%
2023 NZ$0.32 B-32.36%
2022 NZ$0.48 B-35.56%
2021 NZ$0.74 B25.7%
2020 NZ$0.59 B52.11%
2019 NZ$0.39 B10.77%
2018 NZ$0.35 B56.59%
2017 NZ$0.22 B125.53%
2016 NZ$99.74 M-417.36%
2015 -NZ$31.44 Million-74.49%
2014 -NZ$0.13 Billion-25.19%
2013 -NZ$0.17 Billion430.06%
2012 -NZ$31.07 Million-83.92%
2011 -NZ$0.2 Billion39.82%
2010 -NZ$0.14 Billion2.84%
2009 -NZ$0.14 Billion-8.62%
2008 -NZ$0.15 Billion-47.92%
2007 -NZ$0.29 Billion-5.92%
2006 -NZ$0.31 Billion19.8%
2005 -NZ$0.26 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.39 Billion-138.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$30.42 Million-103.03%๐Ÿ‡บ๐Ÿ‡ธ USA